menu
    • menu

    Company profile for Precision Dermatology, Inc.

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Willow Birch Pharma delivers trusted, high-quality APIs nationwide with unmatched service, compliance, and competitive value.

    Virtual Booth

    Contact Supplier

    AMI Lifesciences is Driven by Chemistry. Powered by People.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    We are a significant player in the rapidly growing dermatology and skincare markets. PreCision Dermatology plans to expand quickly through acquisitions, in-licensing, co-marketing opportunities and by commercializing its own breakthrough products to allow everyone to benefit from healthy, beautiful skin. Led by an experienced senior management team and an eminent group of scientific advisors, PreCision Dermatology aims ...
    We are a significant player in the rapidly growing dermatology and skincare markets. PreCision Dermatology plans to expand quickly through acquisitions, in-licensing, co-marketing opportunities and by commercializing its own breakthrough products to allow everyone to benefit from healthy, beautiful skin. Led by an experienced senior management team and an eminent group of scientific advisors, PreCision Dermatology aims to operate in the key segments of the dermatology market. The PreCision team is dedicated to developing products backed by rigorous science that fulfill unmet therapeutic needs in dermatology. Through the Company’s recent acquisition of Onset Dermatologics LLC (www.onsetdermatologics.com), a prescription dermatology company with a portfolio of unique marketed products, PreCision gained product development and regulatory expertise, an extensive product pipeline backed by intellectual property, a full cGMP state-of-the-art manufacturing facility and an established, highly trained national sales force focused on dermatologists. These core building blocks provide PreCision Dermatology with a solid foundation for expansion and success.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Precision Dermatology, Inc.United_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    900 Highland Corporate Drive, Cumberland, RI 02864 USA
    Telephone
    Telephone
    1. (888) 713-8154 2. 646-895-9540(new york office)
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    http://www.precisionderm.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    DCAT Week

    DCAT Week

    Not Confirmed

    envelop Contact Supplier

    DCAT Week

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Azitra Announces Proposed Public Offering of Common Stock
    Azitra Announces Proposed Public Offering of Common Stock

    14 Jan 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/azitra-announces-proposed-public-offering-of-common-stock-302350978.html

    PR NEWSWIRE
    14 Jan 2025
    Share Share

    Inspections and registrations

    Upload your audits for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search